3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
68
Lymphoma, Non-Hodgkin
53
Lymphoma, Large B-Cell, Diffuse
47
Hodgkin Disease
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Leukemia, Myeloid, Acute
41
Small Cell Lung Carcinoma
37
Leukemia
37
Burkitt Lymphoma
32
Lymphoma, Mantle-Cell
29
Lymphoma, Follicular
28
Lung Neoplasms
20
Carcinoma, Non-Small-Cell Lung
20
Multiple Myeloma
19
Congenital Abnormalities
18
Lymphoma, Large-Cell, Immunoblastic
17
Lymphoma, Large-Cell, Anaplastic
17
Recurrence
15
Lymphoma, B-Cell, Marginal Zone
15
Lymphoma, B-Cell
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Neuroblastoma
13
Neoplasms
13
Myelodysplastic Syndromes
11
Waldenstrom Macroglobulinemia
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, T-Cell
10
Immunoblastic Lymphadenopathy
10
Sarcoma
9
Myeloproliferative Disorders
9
Interventions
Trastuzumab
3
Sugammadex
2
Neostigmine
2
Cisplatin
2
valrubicin
1
tucatinib
1
pembrolizumab
1
niraparib
1
enfortumab vedotin
1
avelumab
1
atezolizumab
1
Surveys and Questionnaires
1
Sunitinib
1
Standard of Care
1
Rocuronium
1
Pemetrexed
1
Paclitaxel
1
Nephroureterectomy
1
Neoadjuvant Therapy
1
Mitomycin
1
Lymph Node Excision
1
Glycopyrrolate
1
Gemcitabine
1
GSK-3326595
1
Fulvestrant
1
Docetaxel
1
Cetuximab
1
Afatinib
1
Administration, Intravesical
1
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urologic Neoplasms
×
Etoposide
×
Clear all
No trials found.